Past the pill and product: What do VCs want?
During a panel at MedCity INVEST, four experts addressed what VCs and potential acquirers are looking for in emerging companies.
SERMO’s new by physicians, for physicians drug ratings tool
SERMO, a physician social network, has unveiled its "Drug Ratings" tool, which allows doctors to research, rate and share their experiences with the accessibility of specific drugs.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Study: One third of drugs had safety issues years after FDA approved them
It took a median time period of 4.2 years after the drugs were approved for these safety concerns to come to light, the report by Yale School of Medicine said.
presented by
Has factory consolidation for pharma companies heightened risk of drug shortages?
Consolidation, driven by cost-cutting, drug company mergers and outsourcing of manufacturing, has prompted hospital pharmacists and health policy experts to fear that one misstep could spell disaster for patients.
If Trump blusters, industry should shrug and carry on
Greg Simon who was at the J.P. Morgan Healthcare Conference to discuss the Cancer Moonshot criticized President-elect Trump's stance on pharma companies and exhorted the industry to respond rationally.
Abbvie’s Viekira Pak Costs $6.5 Million a Year in Avoidable Costs, Puts Patients at Greater Risk
Abbvie’s Viekira Pak Costs $6.5 Million a Year in Avoidable Costs, Puts Patients at Greater Risk// // In January 2015, Advera Health released a Drug Safety Monitor analysis comparing the safety of then newly approved Hepatitis C drugs Viekira Pak to Harvoni and Solvaldi (hereafter just Harvoni). Our analysts concluded, …both Harvoni and Sovaldi appear […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Non-Negotiable Cost of Drugs
In the past several months the “war on drugs” has intensified. But the war is no longer defined as an offensive against illegal narcotics, but one against pharmaceutical companies and the increasing costs of specialty drugs. With the donkeys, elephants, and other political animals gearing up for the 2016 electoral stampede, it seems that each […]
Blame Canada
First, a disclosure. I am Canadian. Well, I’m actually a dual U.S. – Canadian citizen. I was born in Toronto to a U.S. parent and lived there until my family moved to California when I was 15. Among other things, that means that I have two passports and that my kids are also dual citizens. […]
Wow of the Week: Spiders on speed
Drugs are whack: The intricate patternings of spider webs are completely morphed when they’re high, or so say two studies – one in 1948 and the other in 1995 – that show the stunning differences you’ll find in a spider’s webs when they’ve had caffeine, LSD, speed and a number of other drugs. The spiders didn’t […]
Death penalty policy causes docs to worry over obtaining anesthesia for patients
An unlikely candidate is at the center of a capital punishment debate: propofol, the anesthesia many physicians use to put patients under. Why? A shortage on the anesthetic drugs used for lethal injection caused state governments to look elsewhere for sedatives, the Scientific American reports. Propofol, used up to 50 million times a year in US […]
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Healthcare design firm creates user-friendly auto-injector rheumatoid arthritis patients
A British healthcare design firm has come out with a new drug-delivery device to add to its innovative portfolio: an auto-injector for rheumatoid arthritis patients. On its head, this might not sound super-glamorous for a firm like Cambridge Consultants, but the design of Aira is much more user-friendly than many other models currently on the […]
Biocrossroads picks seven Indiana health IT, life science startups to compete for venture capital
Biocrossroads, which provides money and support to Indiana’s life sciences industry, announced the seven finalists who stand to gain startup funding in its annual New Venture Competition. Six have biotech or healthcare in their sights. On Oct. 21, five of these companies will compete for $25,000 and access to the Indiana Seed II Fund‘s staff […]
Cartoon shows why enrolling in Obamacare might remind us of watching pharma commercials
Since enrollment in the federal health insurance exchanges opened last week, “glitchy” has been a key word. Though Secretary of HHS Kathleen Sebelius told Jon Stewart the website is getting better every day (and John Green points to how even with the server errors it’s faster than applying for private insurance), this comparison of Obamacare […]
FDA plans to use $43K a year on Twitter, Facebook. This sequestration spend outrages some Republicans
The FDA could spend up to $182,000 over the next four years on its social media plans. The money goes to IB5k, which helped President Obama with his first campaign for the White House, as well as doing some work for leading Republicans, according to Politico. Overall, according to the RFQ, the job involves: By […]
Pharma’s shifting strategy means more jobs for computational biologists
An article discussing the burgeoning field of Computational Biology was just published on the Science Careers website. For the biopharmaceutical industry, big data is the abundant and ever-growing compendium of disease associations and genomic data that is (in many cases) publicly available. Instead of following the traditional pharma paradigm of systematically testing the effects of […]